Clinical Trials Logo

Clinical Trial Summary

A prospective randomized study to compare the adjunctive use of high dose omeprazole infusion against scheduled second endoscopy in prevention of peptic ulcer rebleeding after therapeutic endoscopy.


Clinical Trial Description

We have previously performed a prospective randomized controlled trial on the effect of scheduled second endoscopy upon peptic ulcer rebleeding. We found that the rate of recurrent bleeding was significantly reduced from 13.8% to 5% with a scheduled second endoscopy and appropriate therapy performed within 24 hours after initial hemostasis.

When we look at the studies in the literature employing proton pump inhibitors (PPI) infusion after primary endoscopic therapy, we found that there was also a significant reduction in the rate of rebleeding, the number of operation performed and the transfusion requirement.

Controversy exists regarding the optimal strategy to minimize recurrent peptic ulcer bleeding after successful endoscopic hemostasis. A recent cost-effective analysis on various strategies showed that selective scheduled second endoscopy strategy was probably the most effective and least expensive to prevent recurrent peptic ulcer bleeding.

We conduct a randomized trial on the cost-effectiveness of using omeprazole infusion vs scheduled second endoscopy on the management of bleeding peptic ulcers. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00164931
Study type Interventional
Source Chinese University of Hong Kong
Contact
Status Completed
Phase Phase 3
Start date October 2003

See also
  Status Clinical Trial Phase
Completed NCT01125852 - Supplementary Angiographic Embolization for Peptic Ulcer Bleeding N/A
Completed NCT00840008 - The Dissemination of Consensus Recommendations on Upper Gastrointestinal Bleeding Phase 4
Terminated NCT00164905 - Role of Doppler Ultrasound in Severe Peptic Ulcer Hemorrhage N/A
Completed NCT05563714 - Anticoagulation With Enhanced Gastrointestinal Safety N/A
Completed NCT03362281 - Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients Phase 3
Completed NCT04211194 - Registry for Upper Gastrointestinal Bleeding
Completed NCT01241266 - China Survey of Peptic Ulcer Bleeding N/A
Completed NCT00037570 - Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage Phase 2
Completed NCT00731601 - Intravenous Proton Pump Inhibitor for Peptic Ulcer Bleeding Phase 4
Completed NCT05248321 - Precise Delivery of Tranexamic Acid to Enhance Endoscopic Hemostasis for Peptic Ulcer Bleeding N/A
Recruiting NCT00687336 - Helicobacter Pylori Empiric Treatment in Ulcer Bleeding Phase 4
Not yet recruiting NCT06273384 - Diagnostic Performance of CIM for Helicobacter Pylori Infection in Patients With Peptic Ulcer Bleeding
Terminated NCT00165009 - Resolution Endoclips Vs Epinephrine Injection and Heater Probe Phase 3
Completed NCT03163680 - Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers
Completed NCT00279123 - Effects of 2 Different Doses of Pantoprazole on Gastric pH and Recurrent Bleeding in Patients Who Bled From Peptic Ulcers Phase 4
Completed NCT03362268 - IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients Phase 2
Completed NCT00573924 - Trial of Oral Versus Intravenous Proton Pump Inhibitor on Intragastric pH in Patients With Bleeding Ulcers N/A
Withdrawn NCT02724150 - Comparison of Low Against High Regimen of Proton Pump Inhibitors for Treatment of Acute Peptic Ulcer Bleeding Phase 4
Active, not recruiting NCT04536428 - ClearEndoclip Versus EZ Clip for Upper Gastrointestinal Ulcer Bleeding N/A
Completed NCT02197039 - The Selection Criteria for the Second-look Endoscopy Among Patients With Bleeding Peptic Ulcers